Could taking drug holidays improve skin cancer treatment?
NCT ID NCT05651828
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 23 times
Summary
This study compares four different dosing schedules of the drug vismodegib in 34 adults with advanced basal cell carcinoma. The goal is to see if personalized, intermittent dosing works as well as continuous daily dosing while reducing side effects. Participants will be followed to measure how long the treatment remains effective and how well tumors shrink.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33617, United States
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.